Bayer Aktiengesellschaft (BAYRY)

OTC Markets OTCQX • Currently down 0.22 (-1.65%) in today's trading session

1 member of Congress has disclosed 8 trades in Bayer Aktiengesellschaft (BAYRY) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 11 April 2019. Aggregate disclosed activity totals roughly $32K in purchases and $32K in sales (midpoint estimates from bracketed disclosure amounts).

Bayer Aktiengesellschaft is currently trading at $13.12, positioned at 74% of its 52-week range ($7.19 – $15.23).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$13.12
24h Change
-0.22 (-1.65%)
52 Week Range
$7.19—$15.23
View on NASDAQ

Bayer Aktiengesellschaft Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BAYRY

Select to highlight on chart
3 transactions
Compliance: 38%
Josh Gottheimer11 Apr 201920 May 2019SaleStock$1,001 - $15,000N/A
Josh Gottheimer11 Jan 201931 Jan 2019PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer12 Dec 20184 Jan 2019SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$51.56B

Volume

104.17K

Beta

0.83

P/E Ratio

8.81

Fundamentals

EPS

$1.49

Div. Yield

0.24%

Open

$13.10

Day Range

$13.07 — $13.24

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC · USD
Country
DE
CEO
William N. Anderson
IPO Date
1996-11-18
Website
www.bayer.com

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science...

Earnings

Next Report

Q2 2026

4 Aug

EPS Est.

$0.23

Rev. Est.

$12.3B

Days Until

12

Recent Quarters

Q1 202612 May
EPS$0.79
Beat 23.4%
Q4 20254 Mar
EPS$0.18
Beat 0.0%
Q3 202512 Nov
EPS$0.17
Beat 30.8%
Q2 20256 Aug
EPS$0.35
Beat 40.0%
Q4 20245 Mar
EPS$0.28
Beat 0.0%
Q3 202431 Dec
EPS$-0.09
Q3 202412 Nov
EPS$0.07
Miss 58.8%
Q2 20246 Aug
EPS$0.25
Beat 0.0%
Q1 202414 May
EPS$0.77
Beat 68.9%
Q4 202327 Feb
EPS$0.50
Beat 11.1%
Q3 20238 Nov
EPS$0.10
Miss 64.3%
Q2 20238 Aug
EPS$0.33
Miss 15.4%
Q1 202311 May
EPS$0.79
Beat 43.6%
Q4 202228 Feb
EPS$0.34
Beat 6.3%
Q3 20228 Nov
EPS$0.29
Miss 3.3%
Q2 20224 Aug
EPS$0.51
Beat 10.9%
Q1 202210 May
EPS$0.99
Beat 28.6%
Q3 202131 Dec
EPS$0.33
Q3 20219 Nov
EPS$0.31
Beat 3.3%
Q2 20215 Aug
EPS$0.48
Beat 2.1%
Q1 202112 May
EPS$0.78
Beat 1.3%
Q4 202023 Feb
EPS$0.39
Beat 0.0%
Q3 20203 Nov
EPS$0.24
Miss 11.1%
Q2 20204 Aug
EPS$0.44
Beat 0.0%
Q1 202027 Apr
EPS$0.74
Beat 37.0%
Q4 201927 Feb
EPS$0.35
Beat 2.9%
Q3 201930 Oct
EPS$0.32
Beat 10.3%
Q2 201930 Jul
EPS$0.46
Beat 0.0%
Q1 201925 Apr
EPS$0.72
Beat 53.2%
Q4 201827 Feb
EPS$0.31
Beat 19.2%
Q3 201813 Nov
EPS$0.35
Miss 14.6%
Q1 201830 Jun
EPS$0.25
Q1 20183 May
EPS$0.69
Miss 2.8%
Q4 201728 Feb
EPS$0.42
Beat 35.5%
Q3 201726 Oct
EPS$0.43
Beat 48.3%
Q2 201727 Jul
EPS$0.50
Beat 6.4%
Q1 201727 Apr
EPS$0.70
Beat 16.7%
Q4 201622 Feb
EPS$0.33
Beat 0.0%
Q3 201626 Oct
EPS$0.48
Beat 4.3%
Q2 201627 Jul
EPS$0.58
Beat 5.5%
Q1 201626 Apr
EPS$0.66
Beat 4.8%
Q4 201525 Feb
EPS$0.29
Miss 9.4%
Q3 201529 Oct
EPS$0.47
Beat 14.6%
Q2 201529 Jul
EPS$0.55
Beat 7.8%
Q1 201530 Apr
EPS$0.58
Miss 1.7%
Q4 201426 Feb
EPS$0.34
Q3 201430 Oct
EPS$0.43
Q2 201430 Jul
EPS$0.51
Q1 201424 Apr
EPS$0.59
Miss 4.8%
Q4 201328 Feb
EPS$0.38
Q3 201331 Oct
EPS$0.42
Q2 201331 Jul
EPS$0.51
Q1 201325 Apr
EPS$0.55
Q4 201228 Feb
EPS$0.31
Miss 16.2%
Q2 201230 Sept
EPS$0.20
Q1 201230 Jun
EPS$0.18
Q4 201131 Mar
EPS$0.42
Q3 201131 Dec
EPS$0.13
Q2 201130 Sept
EPS$0.26
Q1 201130 Jun
EPS$0.33
Q4 201031 Mar
EPS$0.29
Q3 201031 Dec
EPS$-0.07
Q2 201030 Sept
EPS$0.12
Q1 201030 Jun
EPS$0.20
Q4 200931 Mar
EPS$0.26
Q3 200931 Dec
EPS$0.06
Q2 200930 Sept
EPS$0.11
Q1 200930 Jun
EPS$0.23
Q4 200831 Mar
EPS$0.18
Q3 200831 Dec
EPS$0.04
Q2 200830 Sept
EPS$0.12
Q1 200830 Jun
EPS$0.27
Q4 200731 Mar
EPS$0.36
Q3 200731 Dec
EPS$0.02
Q2 200730 Sept
EPS$0.51
Q1 200730 Jun
EPS$0.27
Q4 200631 Mar
EPS$1.14
Q3 200631 Dec
EPS$0.11
Q2 200630 Sept
EPS$0.12
Q1 200630 Jun
EPS$0.18
Q4 200531 Mar
EPS$0.25
Q3 200531 Dec
EPS$0.02
Q2 200530 Sept
EPS$0.20
Q1 200530 Jun
EPS$0.06
Q4 200431 Mar
EPS$0.29
Q3 200431 Dec
EPS$0.02
Q2 200430 Sept
EPS$0.01
Q1 200430 Jun
EPS$0.05
Q4 200331 Mar
EPS$0.17
Q3 200331 Dec
EPS$-0.76
Q2 200330 Sept
EPS$-0.05
Q1 200330 Jun
EPS$0.05
Q4 200231 Mar
EPS$0.22
Q3 200231 Dec
EPS$-0.13
Q2 200230 Sept
EPS$0.22
Q1 200230 Jun
EPS$0.10
Q4 200131 Mar
EPS$0.16
Q3 200131 Dec
EPS$0.02
Q2 200130 Sept
EPS$-0.06
Q1 200130 Jun
EPS$0.16
Q4 200031 Mar
EPS$0.13

2 politicians traded within 30 days

Dividends

Dividend History

28 Apr 2026
Amount $0.0321
29 Apr 2025
Amount $0.0311
29 Apr 2024
Amount $0.0294
2 May 2023
Amount $0.6602
2 May 2022
Amount $0.5258
28 Apr 2021
Amount $0.6041
29 Apr 2020
Amount $0.7626
29 Apr 2019
Amount $0.7823
22 Jun 2018
Amount $0.4162
25 May 2018
Amount $0.8131
1 May 2017
Amount $0.7391
27 Apr 2016
Amount $0.7169
22 May 2015
Amount $0.6153
25 Apr 2014
Amount $0.7238
24 Apr 2013
Amount $0.6195
25 Apr 2012
Amount $0.5365
27 Apr 2011
Amount $0.5536
28 Apr 2010
Amount $0.4612
8 May 2009
Amount $0.4732
23 Apr 2008
Amount $0.5241
25 Apr 2007
Amount $0.3398
26 Apr 2006
Amount $0.2988
27 Apr 2005
Amount $0.1766
8 Feb 2005
Amount $0.4851
28 Apr 2004
Amount $0.1492
23 Apr 2003
Amount $0.2526
24 Apr 2002
Amount $0.2024
25 Apr 2001
Amount $0.3099
26 Apr 2000
Amount $0.2936
28 Apr 1999
Amount $0.2698
1 May 1998
Amount $0.2665
28 Apr 1997
Amount $0.1812
23 Apr 1996
Amount $0.1789
20 Apr 1995
Amount $0.1732

Stock Splits

Split History

6 Jun 2018Stock Split
Ratio203:200
20 Sept 2017Stock Split
Ratio4:1
25 Sept 1995Stock Split
Ratio10:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BAYRY

Which members of Congress have traded BAYRY?
1 member of Congress has disclosed 8 trade in Bayer Aktiengesellschaft (BAYRY) under the STOCK Act: Josh Gottheimer.
When was BAYRY most recently disclosed by Congress?
The most recent BAYRY disclosure was a sale by Josh Gottheimer on 11 April 2019.
What is the total disclosed congressional trading volume for BAYRY?
Members of Congress have disclosed approximately $32K in BAYRY purchases and $32K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in BAYRY?
This BAYRY page updates as soon as new STOCK Act disclosures are filed for Bayer Aktiengesellschaft. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.